Changes in plasma levels of per- and polyfluoroalkyl substances (PFAS) are associated with changes in plasma lipids - A longitudinal study over 10 years

Associations between per- and polyfluoroalkyl substances (PFAS), mainly PFOS and PFOA, and increased blood lipids have been reported primarily from cross-sectional studies. The aim of the present study was to investigate associations between multiple PFAS and blood lipids in a longitudinal fashion....

Full description

Saved in:
Bibliographic Details
Published inEnvironmental research Vol. 211; p. 112903
Main Authors Dunder, Linda, Lind, P. Monica, Salihovic, Samira, Stubleski, Jordan, Kärrman, Anna, Lind, Lars
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Inc 01.08.2022
Subjects
and polyfluoroalkyl substances
confidence interval
drug therapy
Dyslipidemia
Epidemiology
high density lipoprotein cholesterol
humans
lipid metabolism
longitudinal studies
Longitudinal study
low density lipoprotein cholesterol
Per
Per- and polyfluoroalkyl substances
PFAS
physical activity
Plasma lipids
prospective studies
regression analysis
Sweden
tandem mass spectrometry
Sweden
Per- and polyfluoroalkyl substances
Epidemiology
PFAS
Plasma lipids
Longitudinal study
Dyslipidemia
Online AccessGet full text

Cover

Abstract Associations between per- and polyfluoroalkyl substances (PFAS), mainly PFOS and PFOA, and increased blood lipids have been reported primarily from cross-sectional studies. The aim of the present study was to investigate associations between multiple PFAS and blood lipids in a longitudinal fashion. A total of 864 men and women aged 70 years and free from lipid medication were included from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study from Uppsala Sweden, 614 and 404 of those were reinvestigated at age 75 and 80. At all three occasions, eight PFAS were measured in plasma using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Total cholesterol, triglycerides, low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) were also measured in plasma at all three occasions. Mixed-effects linear regression models were used to examine the relationship between the changes in PFAS levels and changes in lipid levels. Changes in plasma levels of six out of the eight investigated PFAS were positively associated with changes in plasma lipids after adjustment for sex, change in body mass index (BMI), smoking, physical activity, statin use (age was the same in all subjects), and correction for multiple testing. For example, changes in perfluorodecanoic acid (PFDA) were positively associated with the changes in total cholesterol (β: 0.23, 95% confidence interval (CI): 0.14 to 0.32), triglycerides (β: 0.08, 95% CI: 0.04–0.12) and HDL-cholesterol (β: 0.08, 95% CI: 0.04–0.11). In this longitudinal study with three measurements over 10 years of both plasma PFAS and lipids, changes in six out of the eight investigated PFAS were positively associated with changes in plasma lipids, giving further support for a role of PFAS exposure in human lipid metabolism. [Display omitted] •Plasma levels of PFAS and lipids were measured three times over 10 years.•Six out of the eight analyzed PFAS were positively associated with plasma lipids.•This study gives further evidence of PFAS exposure in human lipid metabolism.
AbstractList Associations between per- and polyfluoroalkyl substances (PFAS), mainly PFOS and PFOA, and increased blood lipids have been reported primarily from cross-sectional studies. The aim of the present study was to investigate associations between multiple PFAS and blood lipids in a longitudinal fashion.BACKGROUNDAssociations between per- and polyfluoroalkyl substances (PFAS), mainly PFOS and PFOA, and increased blood lipids have been reported primarily from cross-sectional studies. The aim of the present study was to investigate associations between multiple PFAS and blood lipids in a longitudinal fashion.A total of 864 men and women aged 70 years and free from lipid medication were included from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study from Uppsala Sweden, 614 and 404 of those were reinvestigated at age 75 and 80. At all three occasions, eight PFAS were measured in plasma using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Total cholesterol, triglycerides, low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) were also measured in plasma at all three occasions. Mixed-effects linear regression models were used to examine the relationship between the changes in PFAS levels and changes in lipid levels.METHODSA total of 864 men and women aged 70 years and free from lipid medication were included from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study from Uppsala Sweden, 614 and 404 of those were reinvestigated at age 75 and 80. At all three occasions, eight PFAS were measured in plasma using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Total cholesterol, triglycerides, low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) were also measured in plasma at all three occasions. Mixed-effects linear regression models were used to examine the relationship between the changes in PFAS levels and changes in lipid levels.Changes in plasma levels of six out of the eight investigated PFAS were positively associated with changes in plasma lipids after adjustment for sex, change in body mass index (BMI), smoking, physical activity, statin use (age was the same in all subjects), and correction for multiple testing. For example, changes in perfluorodecanoic acid (PFDA) were positively associated with the changes in total cholesterol (β: 0.23, 95% confidence interval (CI): 0.14 to 0.32), triglycerides (β: 0.08, 95% CI: 0.04-0.12) and HDL-cholesterol (β: 0.08, 95% CI: 0.04-0.11).RESULTSChanges in plasma levels of six out of the eight investigated PFAS were positively associated with changes in plasma lipids after adjustment for sex, change in body mass index (BMI), smoking, physical activity, statin use (age was the same in all subjects), and correction for multiple testing. For example, changes in perfluorodecanoic acid (PFDA) were positively associated with the changes in total cholesterol (β: 0.23, 95% confidence interval (CI): 0.14 to 0.32), triglycerides (β: 0.08, 95% CI: 0.04-0.12) and HDL-cholesterol (β: 0.08, 95% CI: 0.04-0.11).In this longitudinal study with three measurements over 10 years of both plasma PFAS and lipids, changes in six out of the eight investigated PFAS were positively associated with changes in plasma lipids, giving further support for a role of PFAS exposure in human lipid metabolism.CONCLUSIONIn this longitudinal study with three measurements over 10 years of both plasma PFAS and lipids, changes in six out of the eight investigated PFAS were positively associated with changes in plasma lipids, giving further support for a role of PFAS exposure in human lipid metabolism.
Background: Associations between per-and polyfluoroalkyl substances (PFAS), mainly PFOS and PFOA, and increased blood lipids have been reported primarily from cross-sectional studies. The aim of the present study was to investigate associations between multiple PFAS and blood lipids in a longitudinal fashion. Methods: A total of 864 men and women aged 70 years and free from lipid medication were included from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study from Uppsala Sweden, 614 and 404 of those were reinvestigated at age 75 and 80. At all three occasions, eight PFAS were measured in plasma using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Total cholesterol, triglycerides, low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) were also measured in plasma at all three occasions. Mixed-effects linear regression models were used to examine the relationship between the changes in PFAS levels and changes in lipid levels. Results: Changes in plasma levels of six out of the eight investigated PFAS were positively associated with changes in plasma lipids after adjustment for sex, change in body mass index (BMI), smoking, physical activity, statin use (age was the same in all subjects), and correction for multiple testing. For example, changes in perfluorodecanoic acid (PFDA) were positively associated with the changes in total cholesterol (13: 0.23, 95% confidence interval (CI): 0.14 to 0.32), triglycerides (13: 0.08, 95% CI: 0.04-0.12) and HDL-cholesterol (13: 0.08, 95% CI: 0.04-0.11). Conclusion: In this longitudinal study with three measurements over 10 years of both plasma PFAS and lipids, changes in six out of the eight investigated PFAS were positively associated with changes in plasma lipids, giving further support for a role of PFAS exposure in human lipid metabolism.
Associations between per- and polyfluoroalkyl substances (PFAS), mainly PFOS and PFOA, and increased blood lipids have been reported primarily from cross-sectional studies. The aim of the present study was to investigate associations between multiple PFAS and blood lipids in a longitudinal fashion. A total of 864 men and women aged 70 years and free from lipid medication were included from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study from Uppsala Sweden, 614 and 404 of those were reinvestigated at age 75 and 80. At all three occasions, eight PFAS were measured in plasma using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Total cholesterol, triglycerides, low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) were also measured in plasma at all three occasions. Mixed-effects linear regression models were used to examine the relationship between the changes in PFAS levels and changes in lipid levels. Changes in plasma levels of six out of the eight investigated PFAS were positively associated with changes in plasma lipids after adjustment for sex, change in body mass index (BMI), smoking, physical activity, statin use (age was the same in all subjects), and correction for multiple testing. For example, changes in perfluorodecanoic acid (PFDA) were positively associated with the changes in total cholesterol (β: 0.23, 95% confidence interval (CI): 0.14 to 0.32), triglycerides (β: 0.08, 95% CI: 0.04–0.12) and HDL-cholesterol (β: 0.08, 95% CI: 0.04–0.11). In this longitudinal study with three measurements over 10 years of both plasma PFAS and lipids, changes in six out of the eight investigated PFAS were positively associated with changes in plasma lipids, giving further support for a role of PFAS exposure in human lipid metabolism.
Associations between per- and polyfluoroalkyl substances (PFAS), mainly PFOS and PFOA, and increased blood lipids have been reported primarily from cross-sectional studies. The aim of the present study was to investigate associations between multiple PFAS and blood lipids in a longitudinal fashion. A total of 864 men and women aged 70 years and free from lipid medication were included from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study from Uppsala Sweden, 614 and 404 of those were reinvestigated at age 75 and 80. At all three occasions, eight PFAS were measured in plasma using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Total cholesterol, triglycerides, low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) were also measured in plasma at all three occasions. Mixed-effects linear regression models were used to examine the relationship between the changes in PFAS levels and changes in lipid levels. Changes in plasma levels of six out of the eight investigated PFAS were positively associated with changes in plasma lipids after adjustment for sex, change in body mass index (BMI), smoking, physical activity, statin use (age was the same in all subjects), and correction for multiple testing. For example, changes in perfluorodecanoic acid (PFDA) were positively associated with the changes in total cholesterol (β: 0.23, 95% confidence interval (CI): 0.14 to 0.32), triglycerides (β: 0.08, 95% CI: 0.04-0.12) and HDL-cholesterol (β: 0.08, 95% CI: 0.04-0.11). In this longitudinal study with three measurements over 10 years of both plasma PFAS and lipids, changes in six out of the eight investigated PFAS were positively associated with changes in plasma lipids, giving further support for a role of PFAS exposure in human lipid metabolism.
BACKGROUND: Associations between per- and polyfluoroalkyl substances (PFAS), mainly PFOS and PFOA, and increased blood lipids have been reported primarily from cross-sectional studies. The aim of the present study was to investigate associations between multiple PFAS and blood lipids in a longitudinal fashion. METHODS: A total of 864 men and women aged 70 years and free from lipid medication were included from the PIVUS study, 614 and 404 of those were reinvestigated at age 75 and 80. At all three occasions, eight PFAS were measured in plasma using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Total cholesterol, triglycerides, low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) were also measured in plasma at all three occasions. Mixed-effects linear regression models were used to examine the relationship between the changes in PFAS levels and changes in lipid levels. RESULTS: Changes in plasma levels of six out of the eight investigated PFAS were positively associated with changes in plasma lipids after adjustment for sex, change in body mass index (BMI), smoking, physical activity, statin use (age was the same in all subjects), and correction for multiple testing. For example, changes in perfluorodecanoic acid (PFDA) were positively associated with the changes in total cholesterol (β: 0.23, 95% confidence interval (CI): 0.14 to 0.32), triglycerides (β: 0.08, 95% CI: 0.04-0.12) and HDL-cholesterol (β: 0.08, 95% CI: 0.04-0.11). CONCLUSION: In this longitudinal study with three measurements over 10 years of both plasma PFAS and lipids, changes in six out of the eight investigated PFAS were positively associated with changes in plasma lipids, giving further support for a role of PFAS exposure in human lipid metabolism.
Associations between per- and polyfluoroalkyl substances (PFAS), mainly PFOS and PFOA, and increased blood lipids have been reported primarily from cross-sectional studies. The aim of the present study was to investigate associations between multiple PFAS and blood lipids in a longitudinal fashion. A total of 864 men and women aged 70 years and free from lipid medication were included from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study from Uppsala Sweden, 614 and 404 of those were reinvestigated at age 75 and 80. At all three occasions, eight PFAS were measured in plasma using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Total cholesterol, triglycerides, low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) were also measured in plasma at all three occasions. Mixed-effects linear regression models were used to examine the relationship between the changes in PFAS levels and changes in lipid levels. Changes in plasma levels of six out of the eight investigated PFAS were positively associated with changes in plasma lipids after adjustment for sex, change in body mass index (BMI), smoking, physical activity, statin use (age was the same in all subjects), and correction for multiple testing. For example, changes in perfluorodecanoic acid (PFDA) were positively associated with the changes in total cholesterol (β: 0.23, 95% confidence interval (CI): 0.14 to 0.32), triglycerides (β: 0.08, 95% CI: 0.04–0.12) and HDL-cholesterol (β: 0.08, 95% CI: 0.04–0.11). In this longitudinal study with three measurements over 10 years of both plasma PFAS and lipids, changes in six out of the eight investigated PFAS were positively associated with changes in plasma lipids, giving further support for a role of PFAS exposure in human lipid metabolism. [Display omitted] •Plasma levels of PFAS and lipids were measured three times over 10 years.•Six out of the eight analyzed PFAS were positively associated with plasma lipids.•This study gives further evidence of PFAS exposure in human lipid metabolism.
ArticleNumber 112903
Author Dunder, Linda
Lind, P. Monica
Stubleski, Jordan
Salihovic, Samira
Kärrman, Anna
Lind, Lars
Author_xml – sequence: 1
  givenname: Linda
  orcidid: 0000-0002-9288-7942
  surname: Dunder
  fullname: Dunder, Linda
  email: linda.dunder@medsci.uu.se
  organization: Department of Medical Sciences, Occupational and Environmental Medicine, Uppsala University, Uppsala, Sweden
– sequence: 2
  givenname: P. Monica
  orcidid: 0000-0002-8949-3555
  surname: Lind
  fullname: Lind, P. Monica
  email: monica.lind@medsci.uu.se
  organization: Department of Medical Sciences, Occupational and Environmental Medicine, Uppsala University, Uppsala, Sweden
– sequence: 3
  givenname: Samira
  surname: Salihovic
  fullname: Salihovic, Samira
  email: samira.salihovic@oru.se
  organization: Inflammatory Response and Infection Susceptibility Centre, School of Medical Sciences, Örebro University, Örebro, Sweden
– sequence: 4
  givenname: Jordan
  surname: Stubleski
  fullname: Stubleski, Jordan
  email: jordan@well-labs.com
  organization: MTM, School of Science and Technology, Örebro University, Örebro, Sweden. Wellington Laboratories Inc, Guelph, ON, Canada
– sequence: 5
  givenname: Anna
  orcidid: 0000-0001-7555-142X
  surname: Kärrman
  fullname: Kärrman, Anna
  email: anna.karrman@oru.se
  organization: MTM, School of Science and Technology, Örebro University, Örebro, Sweden
– sequence: 6
  givenname: Lars
  surname: Lind
  fullname: Lind, Lars
  email: lars.lind@medsci.uu.se
  organization: Department of Medical Sciences, Cardiovascular Epidemiology, Uppsala University, Uppsala, Sweden
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35231461$$D View this record in MEDLINE/PubMed
https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-97722$$DView record from Swedish Publication Index
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-473964$$DView record from Swedish Publication Index
BookMark eNqNkl1rFDEUhoNU7Lb6D0RyWcFZ8zGZDy-EZbUqFBQs3oZscmabNZtMk5kt-0_6c5t1Wi8UrFc5ged9OHDeE3TkgweEXlIyp4RWbzdz8LsIac4IY3NKWUv4EzSjpK0K0gp-hGaEUF60XNBjdJLSJn-p4OQZOuaCcVpWdIZul1fKryFh63HvVNoq7GAHLuHQ4R5igZU3uA9u37kxxKDcz73DaVylQXmdc2ffzhffX2MVAauUgrZqAINv7HCF9d9q21uTcIEX2AW_tsNorFfZl4c9DjuImBK8BxXTc_S0Uy7Bi_v3FF2ef7xcfi4uvn76slxcFFpQMRSVZrVpeGuYoJ2gtSKV6BrGVEWNpqUpS81NY0SdJ-BN07Qr06qWq5yqS8JP0ZtJm26gH1eyj3ar4l4GZeUH-2MhQ1zLcZRlzduq_D88xFG2dc1Yxs8mvI_heoQ0yK1NGpxTHsKYJKtqISre_DI_huajlbzih51f3aPjagvm9xIPV83AuwnQMaQUoZPaDmqwwQ9RWScpkYcKyY2cKiQPFZJThXK4_CP84H8k9n6K5e7AzkKUSVvIFTE2gh6kCfbfgjtva-Ih
CitedBy_id crossref_primary_10_1021_acs_chemrestox_3c00342
crossref_primary_10_1002_jeq2_20511
crossref_primary_10_1016_j_envres_2025_120916
crossref_primary_10_1016_j_envint_2023_108250
crossref_primary_10_1016_j_jhazmat_2024_133891
crossref_primary_10_1007_s11356_023_28739_8
crossref_primary_10_1016_j_scitotenv_2023_167945
crossref_primary_10_1093_toxsci_kfae006
crossref_primary_10_1371_journal_pone_0317678
crossref_primary_10_1016_j_scitotenv_2022_156891
crossref_primary_10_1016_j_scitotenv_2022_158036
crossref_primary_10_3390_toxics12080613
crossref_primary_10_1021_acs_est_3c07533
crossref_primary_10_1289_EHP13195
crossref_primary_10_1016_j_chemosphere_2024_142168
crossref_primary_10_1016_j_ecoenv_2024_116524
crossref_primary_10_1016_j_scitotenv_2024_176227
crossref_primary_10_1039_D4EM00159A
crossref_primary_10_1016_j_envint_2023_107979
crossref_primary_10_20517_wecn_2024_05
crossref_primary_10_3390_toxics11070567
crossref_primary_10_1016_j_jpbao_2023_100002
crossref_primary_10_1289_EHP11840
crossref_primary_10_1016_j_microc_2023_109667
crossref_primary_10_1002_jms_4999
crossref_primary_10_1016_j_envres_2022_114570
crossref_primary_10_3390_foods13071085
crossref_primary_10_1016_j_etap_2023_104062
crossref_primary_10_1016_j_reprotox_2024_108702
crossref_primary_10_1038_s41370_023_00545_x
crossref_primary_10_1016_j_envres_2022_114370
crossref_primary_10_1161_CIRCRESAHA_124_323697
crossref_primary_10_1016_j_aquatox_2025_107312
crossref_primary_10_1016_j_envpol_2024_123615
crossref_primary_10_1016_j_scitotenv_2023_165184
crossref_primary_10_3389_fendo_2024_1261008
crossref_primary_10_1016_j_ecoenv_2024_117599
crossref_primary_10_1016_j_ecoenv_2024_117475
crossref_primary_10_1016_j_chemosphere_2024_141654
crossref_primary_10_1016_j_ecoenv_2023_115751
crossref_primary_10_1016_j_envint_2023_108283
crossref_primary_10_1021_acsestwater_3c00217
crossref_primary_10_1016_j_chemosphere_2024_143072
crossref_primary_10_1093_toxsci_kfae061
crossref_primary_10_3390_toxics10120799
crossref_primary_10_1016_j_envint_2023_107951
crossref_primary_10_1016_j_envint_2024_109117
crossref_primary_10_1016_j_tox_2024_153862
crossref_primary_10_1021_jacs_4c03117
crossref_primary_10_1186_s12940_023_00992_x
crossref_primary_10_1515_reveh_2023_0146
crossref_primary_10_1016_j_fct_2023_113943
crossref_primary_10_1515_reveh_2023_0021
crossref_primary_10_1016_j_fct_2022_113520
crossref_primary_10_1007_s11356_022_23881_1
crossref_primary_10_1177_15598276231162802
crossref_primary_10_1016_j_scitotenv_2024_171305
crossref_primary_10_1289_EHP12351
crossref_primary_10_1055_a_2097_0660
Cites_doi 10.1016/j.tox.2011.06.012
10.1080/15287390802361763
10.1007/s13280-016-0848-8
10.1016/j.envres.2010.07.003
10.1016/j.tox.2006.01.003
10.1097/JOM.0b013e318124a93f
10.1007/s00204-016-1888-3
10.1016/j.ecoenv.2014.04.039
10.1002/etc.204
10.1016/j.metabol.2006.10.019
10.1016/j.envint.2018.04.052
10.1016/j.chemosphere.2014.07.018
10.1007/s11306-021-01853-9
10.1093/toxsci/kfn166
10.1016/j.envint.2020.106091
10.1056/NEJMoa0706628
10.1186/s12940-020-00588-9
10.1080/02772248.2020.1763997
10.1021/es201964x
10.1016/j.scitotenv.2015.01.070
10.1016/j.reprotox.2011.09.009
10.1289/ehp.1307943
10.1097/01.jom.0000052958.59271.10
10.1038/s41370-018-0096-z
10.1016/j.scitotenv.2015.01.042
10.1007/s10661-015-4831-9
10.1161/01.ATV.0000184769.22061.da
10.1093/toxsci/kfn025
10.1093/toxsci/kfm128
10.1093/aje/kwp279
10.1186/s12940-018-0403-0
10.1016/j.envint.2016.08.002
10.1016/j.tox.2017.05.013
10.1016/j.envint.2013.10.004
10.1016/j.marpolbul.2013.12.042
10.3109/01480545.2011.582502
10.1016/j.chroma.2013.07.026
10.1093/toxsci/kfz015
10.1038/s41370-018-0094-1
10.1016/j.bbagen.2012.03.010
10.1016/j.envint.2021.106964
10.1001/archpediatrics.2010.163
10.1016/j.envres.2017.07.050
10.1097/JOM.0b013e318156eca3
10.1289/ehp.0901165
10.1016/j.envint.2017.11.008
10.1056/NEJMoa020194
10.1159/000251722
10.1016/j.tox.2017.01.012
10.1097/EDE.0b013e31829443ee
10.1021/acs.est.6b04806
10.1371/journal.pone.0056969
10.1093/oxfordjournals.aje.a115130
10.1016/j.envint.2015.05.005
10.1093/eurheartj/eht571
10.1080/10408440490464705
10.1016/j.chemosphere.2013.10.005
10.1016/j.envres.2017.10.014
10.1016/j.taap.2020.115204
10.1016/j.tox.2016.12.007
10.1016/j.tox.2011.12.014
10.1016/j.tiv.2019.104700
10.1093/toxsci/kfl014
10.1016/j.envint.2017.08.003
10.1016/j.envint.2020.106117
ContentType Journal Article
Copyright 2022 The Authors
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2022 The Authors
– notice: Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
DBID 6I.
AAFTH
AAYXX
CITATION
NPM
7X8
7S9
L.6
AABEP
ADTPV
AOWAS
D8T
D91
ZZAVC
ACNBI
DF2
DOI 10.1016/j.envres.2022.112903
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
SWEPUB Örebro universitet full text
SwePub
SwePub Articles
SWEPUB Freely available online
SWEPUB Örebro universitet
SwePub Articles full text
SWEPUB Uppsala universitet full text
SWEPUB Uppsala universitet
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList MEDLINE - Academic

AGRICOLA
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
Environmental Sciences
EISSN 1096-0953
ExternalDocumentID oai_DiVA_org_uu_473964
oai_DiVA_org_oru_97722
35231461
10_1016_j_envres_2022_112903
S0013935122002304
Genre Journal Article
GeographicLocations Sweden
GeographicLocations_xml – name: Sweden
GroupedDBID ---
--K
--M
-~X
.DC
.GJ
.~1
0R~
1B1
1RT
1~.
1~5
29G
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
6I.
7-5
71M
8P~
9JM
AACTN
AAEDT
AAEDW
AAFTH
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXUO
AAYJJ
ABEFU
ABFNM
ABFYP
ABJNI
ABLST
ABMAC
ABXDB
ABYKQ
ACDAQ
ACGFS
ACNCT
ACRLP
ADBBV
ADEZE
ADFGL
ADMUD
AEBSH
AEKER
AENEX
AFDAS
AFFNX
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHEUO
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AKIFW
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLECG
BLXMC
C45
CAG
COF
CS3
DM4
DU5
EBS
EFBJH
EFLBG
EJD
EO8
EO9
EP2
EP3
F3I
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HMC
HVGLF
HZ~
IHE
J1W
KCYFY
KOM
L7B
LG5
LY8
M41
MO0
N9A
O-L
O9-
OAUVE
OHT
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
RNS
ROL
RPZ
SDF
SDG
SDP
SEN
SES
SEW
SPCBC
SSJ
SSZ
T5K
TAE
TEORI
TN5
TWZ
UPT
VOH
WH7
WUQ
XOL
XPP
ZCA
ZGI
ZKB
ZMT
ZU3
ZXP
~02
~G-
~KM
AAHBH
AATTM
AAXKI
AAYWO
AAYXX
ACRPL
ACVFH
ADCNI
ADNMO
ADXHL
AEGFY
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRNS
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
BNPGV
CITATION
SSH
NPM
7X8
7S9
L.6
AABEP
ADTPV
AOWAS
D8T
D91
EFKBS
ZZAVC
ACNBI
DF2
ID FETCH-LOGICAL-c515t-6c27d839d251f517a065f822a61dc14d44c3d8d57d44e38889bd9a93a7d87403
IEDL.DBID .~1
ISSN 0013-9351
1096-0953
IngestDate Thu Aug 21 06:52:16 EDT 2025
Thu Aug 21 07:31:33 EDT 2025
Fri Jul 11 01:32:15 EDT 2025
Fri Jul 11 01:43:44 EDT 2025
Thu Apr 03 07:03:31 EDT 2025
Thu Apr 24 23:01:16 EDT 2025
Tue Jul 01 03:06:12 EDT 2025
Fri Feb 23 02:40:24 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords Per- and polyfluoroalkyl substances
Epidemiology
PFAS
Plasma lipids
Longitudinal study
Dyslipidemia
Language English
License This is an open access article under the CC BY license.
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c515t-6c27d839d251f517a065f822a61dc14d44c3d8d57d44e38889bd9a93a7d87403
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-8949-3555
0000-0002-9288-7942
0000-0001-7555-142X
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S0013935122002304
PMID 35231461
PQID 2635243630
PQPubID 23479
ParticipantIDs swepub_primary_oai_DiVA_org_uu_473964
swepub_primary_oai_DiVA_org_oru_97722
proquest_miscellaneous_2675563864
proquest_miscellaneous_2635243630
pubmed_primary_35231461
crossref_citationtrail_10_1016_j_envres_2022_112903
crossref_primary_10_1016_j_envres_2022_112903
elsevier_sciencedirect_doi_10_1016_j_envres_2022_112903
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-08-01
PublicationDateYYYYMMDD 2022-08-01
PublicationDate_xml – month: 08
  year: 2022
  text: 2022-08-01
  day: 01
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Environmental research
PublicationTitleAlternate Environ Res
PublicationYear 2022
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Li, Barregard, Xu, Scott, Pineda, Lindh (bib37) 2020; 19
D'eon, Simpson, Kumar, Baer, Mabury (bib16) 2010; 29
Mora, Fleisch, Rifas-Shiman, Woo Baidal, Pardo, Webster (bib42) 2018; 111
Holmes, Asselbergs, Palmer, Drenos, Lanktree, Nelson (bib29) 2015; 36
Lind, Salihovic, Stubleski, Kärrman, Lind (bib40) 2018; 17
Rosen, Das, Rooney, Abbott, Lau, Corton (bib50) 2017; 387
Salihovic, Stubleski, Kärrman, Larsson, Fall, Lind (bib56) 2018; 117
Frisbee, Shankar, Knox, Steenland, Savitz, Fletcher (bib23) 2010; 164
Graber, Alexander, Laumbach, Black, Strickland, Georgopoulos (bib27) 2019; 29
Abe, Takahashi, Kano, Amaike, Ishii, Maeda (bib1) 2017; 91
Das, Wood, Lin, Starkov, Lau, Wallace (bib17) 2017; 378
Halverstadt, Phares, Wilund, Goldberg, Hagberg (bib28) 2007; 56
Morck, Nielsen, Nielsen, Siersma, Grandjean, Knudsen (bib43) 2015; 129
Carlsson, Lind, Larsson (bib10) 2010; 56
Cho, Lam, Cho, Kannan, Cho (bib14) 2015; 512–513
Canova, Barbieri, Zare Jeddi, Gion, Fabricio, Daprà (bib8) 2020; 145
Cao, Cao, Wang, Wan, Wang (bib9) 2015; 187
Barter, Caulfield, Eriksson, Grundy, Kastelein, Komajda (bib5) 2007; 357
Geiger, Xiao, Ducatman, Frisbee, Innes, Shankar (bib25) 2014; 98
Stubleski, Salihovic, Lind, Lind, van Bavel, Karrman (bib62) 2016; 95
Sunderland, Hu, Dassuncao, Tokranov, Wagner, Allen (bib65) 2019; 29
Eriksen, Raaschou-Nielsen, McLaughlin, Lipworth, Tjønneland, Overvad (bib19) 2013; 8
Eriksen, Raaschou-Nielsen, McLaughlin, Lipworth, Tjonneland, Overvad (bib20) 2013; 8
Li, Barregard, Xu, Scott, Pineda, Lindh (bib36) 2020; 19
Château-Degat, Pereg, Dallaire, Ayotte, Dery, Dewailly (bib12) 2010; 110
Zeng, Qian, Emo, Vaughn, Bao, Qin (bib72) 2015; 512–513
Wan, Zhao, Wei, Hui, Giesy, Wong (bib67) 2012; 1820
Wang, DeWitt, Higgins, Cousins (bib68) 2017; 51
Kraus, Houmard, Duscha, Knetzger, Wharton, McCartney (bib34) 2002; 347
Sinisalu, Yeung, Wang, Pan, Dai, Hyötyläinen (bib58) 2021; 17
Lau, Anitole, Hodes, Lai, Pfahles-Hutchens, Seed (bib35) 2007; 99
Olsen, Burris, Burlew, Mandel (bib45) 2003; 45
Koshy, Attina, Ghassabian, Gilbert, Burdine, Marmor (bib33) 2017; 109
Loveless, Finlay, Everds, Frame, Gillies, O'Connor (bib41) 2006; 220
Sakr, Leonard, Kreckmann, Slade, Cullen (bib54) 2007; 49
Starling, Engel, Whitworth, Richardson, Stuebe, Daniels (bib59) 2014; 62
Wolf, Schmid, Lau, Abbott (bib71) 2012; 33
Vanden Heuvel, Thompson, Frame, Gillies (bib66) 2006; 92
Winquist, Steenland (bib69) 2014; 122
Khalil, Ebert, Honda, Lee, Nahhas, Koskela (bib32) 2018; 160
Rosen, Schmid, Corton, Zehr, Das, Abbott (bib49) 2010
Rotander, Toms, Aylward, Kay, Mueller (bib51) 2015; 82
Salihovic, Kärrman, Lindström, Lind, Lind, van Bavel (bib55) 2013; 1305
Lin, Wen, Lin, Wen, Lien, Chen (bib38) 2011; 45
Chen, Yang, Walker, Thomas, Qiu, Chatzi (bib13) 2020; 145
Austin (bib3) 1989; 129
Steenland, Tinker, Frisbee, Ducatman, Vaccarino (bib61) 2009; 170
Zhu, Wang, Wang, Lu, Giesy (bib74) 2014; 85
Qi, Clark, Timme-Laragy, Park (bib47) 2020; 102
Schlezinger, Puckett, Oliver, Nielsen, Heiger-Bernays, Webster (bib57) 2020; 405
Kennedy, Butenhoff, Olsen, O'Connor, Seacat, Perkins (bib30) 2004; 34
Fitz-Simon, Fletcher, Luster, Steenland, Calafat, Kato (bib21) 2013; 24
Stubleski, Salihovic, Lind, Lind, van Bavel, Kärrman (bib63) 2016; 95
Banzhaf, Filipovic, Lewis, Sparrenbom, Barthel (bib4) 2017; 46
Behr, Plinsch, Braeuning, Buhrke (bib6) 2020; 62
Pouwer, Pieterman, Chang, Olsen, Caspers, Verschuren (bib46) 2019; 168
Curran, Hierlihy, Liston, Pantazopoulos, Nunnikhoven, Tittlemier (bib15) 2008; 71
Chang, Barr, Ryan, Panuwet, Smarr, Liu (bib11) 2022; 158
Rosen, Lee, Ren, Vallanat, Liu, Waalkes (bib48) 2008; 103
Bjork, Butenhoff, Wallace (bib7) 2011; 288
Nelson, Hatch, Webster (bib44) 2010; 118
Glynn, Cantillana, Bjermo (bib26) 2014
Fu, Wang, Fu, Wang, Lu (bib24) 2014; 106
Lind, Fors, Hall, Marttala, Stenborg (bib39) 2005; 25
Elcombe, Elcombe, Foster, Chang, Ehresman, Butenhoff (bib18) 2012; 293
Zhang, Dong, Fan, Zhang, Wang, Jiang (bib73) 2017; 380
Sakr, Leonard, Kreckmann, Slade, Cullen (bib52) 2007; 49
Wolf, Takacs, Schmid, Lau, Abbott (bib70) 2008; 106
Fitzmaurice, Laird, Ware (bib22) 2012
Agency (bib2) 2014
Kerger, Copeland, DeCaprio (bib31) 2011; 34
Stubleski, Salihovic, Lind, Lind, Dunder, McCleaf (bib64) 2017; 159
Starling, Engel, Whitworth, Richardson, Stuebe, Daniels (bib60) 2014; 62
Sakr, Kreckmann, Green, Gillies, Reynolds, Leonard (bib53) 2007; 49
Wan (10.1016/j.envres.2022.112903_bib67) 2012; 1820
Qi (10.1016/j.envres.2022.112903_bib47) 2020; 102
Vanden Heuvel (10.1016/j.envres.2022.112903_bib66) 2006; 92
Bjork (10.1016/j.envres.2022.112903_bib7) 2011; 288
Kraus (10.1016/j.envres.2022.112903_bib34) 2002; 347
Cao (10.1016/j.envres.2022.112903_bib9) 2015; 187
Starling (10.1016/j.envres.2022.112903_bib59) 2014; 62
Nelson (10.1016/j.envres.2022.112903_bib44) 2010; 118
Mora (10.1016/j.envres.2022.112903_bib42) 2018; 111
Lau (10.1016/j.envres.2022.112903_bib35) 2007; 99
Stubleski (10.1016/j.envres.2022.112903_bib62) 2016; 95
Eriksen (10.1016/j.envres.2022.112903_bib19) 2013; 8
Château-Degat (10.1016/j.envres.2022.112903_bib12) 2010; 110
Graber (10.1016/j.envres.2022.112903_bib27) 2019; 29
Li (10.1016/j.envres.2022.112903_bib37) 2020; 19
Canova (10.1016/j.envres.2022.112903_bib8) 2020; 145
Olsen (10.1016/j.envres.2022.112903_bib45) 2003; 45
Wolf (10.1016/j.envres.2022.112903_bib70) 2008; 106
Morck (10.1016/j.envres.2022.112903_bib43) 2015; 129
Salihovic (10.1016/j.envres.2022.112903_bib56) 2018; 117
Sakr (10.1016/j.envres.2022.112903_bib54) 2007; 49
Abe (10.1016/j.envres.2022.112903_bib1) 2017; 91
D'eon (10.1016/j.envres.2022.112903_bib16) 2010; 29
Li (10.1016/j.envres.2022.112903_bib36) 2020; 19
Lind (10.1016/j.envres.2022.112903_bib40) 2018; 17
Glynn (10.1016/j.envres.2022.112903_bib26) 2014
Loveless (10.1016/j.envres.2022.112903_bib41) 2006; 220
Chen (10.1016/j.envres.2022.112903_bib13) 2020; 145
Chang (10.1016/j.envres.2022.112903_bib11) 2022; 158
Elcombe (10.1016/j.envres.2022.112903_bib18) 2012; 293
Agency (10.1016/j.envres.2022.112903_bib2) 2014
Rosen (10.1016/j.envres.2022.112903_bib50) 2017; 387
Winquist (10.1016/j.envres.2022.112903_bib69) 2014; 122
Steenland (10.1016/j.envres.2022.112903_bib61) 2009; 170
Zhang (10.1016/j.envres.2022.112903_bib73) 2017; 380
Kennedy (10.1016/j.envres.2022.112903_bib30) 2004; 34
Austin (10.1016/j.envres.2022.112903_bib3) 1989; 129
Rotander (10.1016/j.envres.2022.112903_bib51) 2015; 82
Sinisalu (10.1016/j.envres.2022.112903_bib58) 2021; 17
Banzhaf (10.1016/j.envres.2022.112903_bib4) 2017; 46
Sakr (10.1016/j.envres.2022.112903_bib53) 2007; 49
Eriksen (10.1016/j.envres.2022.112903_bib20) 2013; 8
Frisbee (10.1016/j.envres.2022.112903_bib23) 2010; 164
Lind (10.1016/j.envres.2022.112903_bib39) 2005; 25
Koshy (10.1016/j.envres.2022.112903_bib33) 2017; 109
Lin (10.1016/j.envres.2022.112903_bib38) 2011; 45
Rosen (10.1016/j.envres.2022.112903_bib49) 2010
Khalil (10.1016/j.envres.2022.112903_bib32) 2018; 160
Barter (10.1016/j.envres.2022.112903_bib5) 2007; 357
Carlsson (10.1016/j.envres.2022.112903_bib10) 2010; 56
Behr (10.1016/j.envres.2022.112903_bib6) 2020; 62
Fu (10.1016/j.envres.2022.112903_bib24) 2014; 106
Schlezinger (10.1016/j.envres.2022.112903_bib57) 2020; 405
Stubleski (10.1016/j.envres.2022.112903_bib64) 2017; 159
Curran (10.1016/j.envres.2022.112903_bib15) 2008; 71
Das (10.1016/j.envres.2022.112903_bib17) 2017; 378
Sunderland (10.1016/j.envres.2022.112903_bib65) 2019; 29
Rosen (10.1016/j.envres.2022.112903_bib48) 2008; 103
Sakr (10.1016/j.envres.2022.112903_bib52) 2007; 49
Fitzmaurice (10.1016/j.envres.2022.112903_bib22) 2012
Zeng (10.1016/j.envres.2022.112903_bib72) 2015; 512–513
Pouwer (10.1016/j.envres.2022.112903_bib46) 2019; 168
Geiger (10.1016/j.envres.2022.112903_bib25) 2014; 98
Zhu (10.1016/j.envres.2022.112903_bib74) 2014; 85
Holmes (10.1016/j.envres.2022.112903_bib29) 2015; 36
Starling (10.1016/j.envres.2022.112903_bib60) 2014; 62
Wolf (10.1016/j.envres.2022.112903_bib71) 2012; 33
Fitz-Simon (10.1016/j.envres.2022.112903_bib21) 2013; 24
Cho (10.1016/j.envres.2022.112903_bib14) 2015; 512–513
Stubleski (10.1016/j.envres.2022.112903_bib63) 2016; 95
Salihovic (10.1016/j.envres.2022.112903_bib55) 2013; 1305
Halverstadt (10.1016/j.envres.2022.112903_bib28) 2007; 56
Kerger (10.1016/j.envres.2022.112903_bib31) 2011; 34
Wang (10.1016/j.envres.2022.112903_bib68) 2017; 51
References_xml – volume: 145
  start-page: 106091
  year: 2020
  ident: bib13
  article-title: Dysregulated lipid and fatty acid metabolism link perfluoroalkyl substances exposure and impaired glucose metabolism in young adults
  publication-title: Environ. Int.
– year: 2014
  ident: bib26
  article-title: Riskvärdering Av Perfluorerande Alkylsyror I Livsmedel Och Dricksvatten
– year: 2014
  ident: bib2
  article-title: PFAA i råvatten och dricksvatten - Resultat av en kartlaggning
– volume: 56
  start-page: 259
  year: 2010
  end-page: 265
  ident: bib10
  article-title: Reference values for 27 clinical chemistry tests in 70-year-old males and females
  publication-title: Gerontology
– volume: 109
  start-page: 128
  year: 2017
  end-page: 135
  ident: bib33
  article-title: Serum perfluoroalkyl substances and cardiometabolic consequences in adolescents exposed to the World Trade Center disaster and a matched comparison group
  publication-title: Environ. Int.
– volume: 1820
  start-page: 1092
  year: 2012
  end-page: 1101
  ident: bib67
  article-title: PFOS-induced hepatic steatosis, the mechanistic actions on β-oxidation and lipid transport
  publication-title: Biochim. Biophys. Acta
– volume: 1305
  start-page: 164
  year: 2013
  end-page: 170
  ident: bib55
  article-title: A rapid method for the determination of perfluoroalkyl substances including structural isomers of perfluorooctane sulfonic acid in human serum using 96-well plates and column-switching ultra-high performance liquid chromatography tandem mass spectrometry
  publication-title: J. Chromatogr. A
– volume: 49
  start-page: 872
  year: 2007
  end-page: 879
  ident: bib52
  article-title: Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluorooctanoate
  publication-title: J. Occup. Environ. Med.
– volume: 8
  year: 2013
  ident: bib19
  article-title: Association between plasma PFOA and PFOS levels and total cholesterol in a middle-aged Danish population
  publication-title: PLoS One
– volume: 187
  start-page: 611
  year: 2015
  ident: bib9
  article-title: Assessment on the distribution and partitioning of perfluorinated compounds in the water and sediment of Nansi Lake, China
  publication-title: Environ. Monit. Assess.
– volume: 170
  start-page: 1268
  year: 2009
  end-page: 1278
  ident: bib61
  article-title: Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant
  publication-title: Am. J. Epidemiol.
– volume: 36
  start-page: 539
  year: 2015
  end-page: 550
  ident: bib29
  article-title: Mendelian randomization of blood lipids for coronary heart disease
  publication-title: Eur. Heart J.
– volume: 512–513
  start-page: 364
  year: 2015
  end-page: 370
  ident: bib72
  article-title: Association of polyfluoroalkyl chemical exposure with serum lipids in children
  publication-title: Sci. Total Environ.
– volume: 49
  start-page: 1086
  year: 2007
  end-page: 1096
  ident: bib53
  article-title: Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers
  publication-title: J. Occup. Environ. Med.
– volume: 45
  start-page: 260
  year: 2003
  end-page: 270
  ident: bib45
  article-title: Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations
  publication-title: J. Occup. Environ. Med.
– volume: 99
  start-page: 366
  year: 2007
  end-page: 394
  ident: bib35
  article-title: Perfluoroalkyl acids: a review of monitoring and toxicological findings
  publication-title: Toxicol. Sci.
– volume: 62
  start-page: 104700
  year: 2020
  ident: bib6
  article-title: Activation of human nuclear receptors by perfluoroalkylated substances (PFAS)
  publication-title: Toxicol. Vitro
– volume: 378
  start-page: 37
  year: 2017
  end-page: 52
  ident: bib17
  article-title: Perfluoroalkyl acids-induced liver steatosis: effects on genes controlling lipid homeostasis
  publication-title: Toxicology
– volume: 122
  start-page: 1299
  year: 2014
  end-page: 1305
  ident: bib69
  article-title: Modeled PFOA exposure and coronary artery disease, hypertension, and high cholesterol in community and worker cohorts
  publication-title: Environ. Health Perspect.
– volume: 387
  start-page: 95
  year: 2017
  end-page: 107
  ident: bib50
  article-title: PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling
  publication-title: Toxicology
– volume: 8
  year: 2013
  ident: bib20
  article-title: Association between plasma PFOA and PFOS levels and total cholesterol in a middle-aged Danish population
  publication-title: PLoS One
– volume: 71
  start-page: 1526
  year: 2008
  end-page: 1541
  ident: bib15
  article-title: Altered fatty acid homeostasis and related toxicologic sequelae in rats exposed to dietary potassium perfluorooctanesulfonate (PFOS)
  publication-title: J. Toxicol. Environ. Health Part A
– volume: 405
  start-page: 115204
  year: 2020
  ident: bib57
  article-title: Perfluorooctanoic acid activates multiple nuclear receptor pathways and skews expression of genes regulating cholesterol homeostasis in liver of humanized PPARα mice fed an American diet
  publication-title: Toxicol. Appl. Pharmacol.
– volume: 19
  start-page: 33
  year: 2020
  ident: bib36
  article-title: Associations between perfluoroalkyl substances and serum lipids in a Swedish adult population with contaminated drinking water
  publication-title: Environ. Health : a global access science source.
– volume: 49
  start-page: 872
  year: 2007
  end-page: 879
  ident: bib54
  article-title: Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluorooctanoate
  publication-title: J. Occup. Environ. Med.
– volume: 103
  start-page: 46
  year: 2008
  end-page: 56
  ident: bib48
  article-title: Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPAR alpha and CAR
  publication-title: Toxicol. Sci. : an official journal of the Society of Toxicology
– volume: 91
  start-page: 2365
  year: 2017
  end-page: 2374
  ident: bib1
  article-title: Activation of nuclear receptor CAR by an environmental pollutant perfluorooctanoic acid
  publication-title: Arch. Toxicol.
– volume: 288
  start-page: 8
  year: 2011
  end-page: 17
  ident: bib7
  article-title: Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes
  publication-title: Toxicology
– volume: 129
  start-page: 203
  year: 2015
  end-page: 209
  ident: bib43
  article-title: PFAS concentrations in plasma samples from Danish school children and their mothers
  publication-title: Chemosphere
– volume: 17
  start-page: 59
  year: 2018
  ident: bib40
  article-title: Changes in plasma levels of perfluoroalkyl substances (PFASs) are related to increase in carotid intima-media thickness over 10 years - a longitudinal study
  publication-title: Environ. Health : a global access science source
– volume: 24
  start-page: 569
  year: 2013
  end-page: 576
  ident: bib21
  article-title: Reductions in serum lipids with a 4-year decline in serum perfluorooctanoic acid and perfluorooctanesulfonic acid
  publication-title: Epidemiology
– volume: 220
  start-page: 203
  year: 2006
  end-page: 217
  ident: bib41
  article-title: Comparative responses of rats and mice exposed to linear/branched, linear, or branched ammonium perfluorooctanoate (APFO)
  publication-title: Toxicology
– volume: 45
  start-page: 10691
  year: 2011
  end-page: 10698
  ident: bib38
  article-title: Associations between levels of serum perfluorinated chemicals and adiponectin in a young hypertension cohort in Taiwan
  publication-title: Environ. Sci. Technol.
– volume: 62
  start-page: 104
  year: 2014
  end-page: 112
  ident: bib60
  article-title: Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study
  publication-title: Environ. Int.
– volume: 110
  start-page: 710
  year: 2010
  end-page: 717
  ident: bib12
  article-title: Effects of perfluorooctanesulfonate exposure on plasma lipid levels in the Inuit population of Nunavik (Northern Quebec)
  publication-title: Environ. Res.
– volume: 29
  start-page: 172
  year: 2019
  end-page: 182
  ident: bib27
  article-title: Per and polyfluoroalkyl substances (PFAS) blood levels after contamination of a community water supply and comparison with 2013–2014 NHANES
  publication-title: J. Expo. Sci. Environ. Epidemiol.
– volume: 98
  start-page: 78
  year: 2014
  end-page: 83
  ident: bib25
  article-title: The association between PFOA, PFOS and serum lipid levels in adolescents
  publication-title: Chemosphere
– volume: 380
  start-page: 23
  year: 2017
  end-page: 29
  ident: bib73
  article-title: Poly- and perfluorinated compounds activate human pregnane X receptor
  publication-title: Toxicology
– volume: 357
  start-page: 2109
  year: 2007
  end-page: 2122
  ident: bib5
  article-title: Effects of torcetrapib in patients at high risk for coronary events
  publication-title: N. Engl. J. Med.
– volume: 46
  start-page: 335
  year: 2017
  end-page: 346
  ident: bib4
  article-title: A review of contamination of surface-, ground-, and drinking water in Sweden by perfluoroalkyl and polyfluoroalkyl substances (PFASs)
  publication-title: Ambio
– volume: 17
  start-page: 103
  year: 2021
  ident: bib58
  article-title: Prenatal exposure to poly-/per-fluoroalkyl substances is associated with alteration of lipid profiles in cord-blood
  publication-title: Metabolomics : Official journal of the Metabolomic Society
– volume: 145
  start-page: 106117
  year: 2020
  ident: bib8
  article-title: Associations between perfluoroalkyl substances and lipid profile in a highly exposed young adult population in the Veneto Region
  publication-title: Environ. Int.
– volume: 111
  start-page: 1
  year: 2018
  end-page: 13
  ident: bib42
  article-title: Early life exposure to per- and polyfluoroalkyl substances and mid-childhood lipid and alanine aminotransferase levels
  publication-title: Environ. Int.
– volume: 82
  start-page: 28
  year: 2015
  end-page: 34
  ident: bib51
  article-title: Elevated levels of PFOS and PFHxS in firefighters exposed to aqueous film forming foam (AFFF)
  publication-title: Environ. Int.
– volume: 29
  start-page: 131
  year: 2019
  end-page: 147
  ident: bib65
  article-title: A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects
  publication-title: J. Expo. Sci. Environ. Epidemiol.
– volume: 92
  start-page: 476
  year: 2006
  end-page: 489
  ident: bib66
  article-title: Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-α, -β, and -γ, liver X receptor-β, and retinoid X receptor-α
  publication-title: Toxicol. Sci.
– volume: 106
  start-page: 246
  year: 2014
  end-page: 252
  ident: bib24
  article-title: Associations between serum concentrations of perfluoroalkyl acids and serum lipid levels in a Chinese population
  publication-title: Ecotoxicol. Environ. Saf.
– volume: 34
  start-page: 396
  year: 2011
  end-page: 404
  ident: bib31
  article-title: Tenuous dose-response correlations for common disease states: case study of cholesterol and perfluorooctanoate/sulfonate (PFOA/PFOS) in the C8 Health Project
  publication-title: Drug Chem. Toxicol.
– volume: 512–513
  start-page: 397
  year: 2015
  end-page: 405
  ident: bib14
  article-title: Concentration and correlations of perfluoroalkyl substances in whole blood among subjects from three different geographical areas in Korea
  publication-title: Sci. Total Environ.
– volume: 293
  start-page: 16
  year: 2012
  end-page: 29
  ident: bib18
  article-title: Hepatocellular hypertrophy and cell proliferation in Sprague-Dawley rats from dietary exposure to potassium perfluorooctanesulfonate results from increased expression of xenosensor nuclear receptors PPARα and CAR/PXR
  publication-title: Toxicology
– volume: 118
  start-page: 197
  year: 2010
  end-page: 202
  ident: bib44
  article-title: Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population
  publication-title: Environ. Health Perspect.
– volume: 19
  start-page: 33
  year: 2020
  ident: bib37
  article-title: Associations between perfluoroalkyl substances and serum lipids in a Swedish adult population with contaminated drinking water
  publication-title: Environ. Health : a global access science source.
– year: 2012
  ident: bib22
  article-title: Applied Longitudinal Analysis
– volume: 117
  start-page: 196
  year: 2018
  end-page: 203
  ident: bib56
  article-title: Changes in markers of liver function in relation to changes in perfluoroalkyl substances - a longitudinal study
  publication-title: Environ. Int.
– volume: 106
  start-page: 162
  year: 2008
  end-page: 171
  ident: bib70
  article-title: Activation of mouse and human peroxisome Proliferator−Activated receptor alpha by perfluoroalkyl acids of different functional groups and chain lengths
  publication-title: Toxicol. Sci.
– volume: 159
  start-page: 95
  year: 2017
  end-page: 102
  ident: bib64
  article-title: The effect of drinking water contaminated with perfluoroalkyl substances on a 10-year longitudinal trend of plasma levels in an elderly Uppsala cohort
  publication-title: Environ. Res.
– volume: 85
  start-page: 619
  year: 2014
  end-page: 627
  ident: bib74
  article-title: Perfluoroalkyl and polyfluoroalkyl substances in sediments from South Bohai coastal watersheds, China
  publication-title: Mar. Pollut. Bull.
– volume: 129
  start-page: 249
  year: 1989
  end-page: 259
  ident: bib3
  article-title: Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond
  publication-title: Am. J. Epidemiol.
– volume: 56
  start-page: 444
  year: 2007
  end-page: 450
  ident: bib28
  article-title: Endurance exercise training raises high-density lipoprotein cholesterol and lowers small low-density lipoprotein and very low-density lipoprotein independent of body fat phenotypes in older men and women
  publication-title: Metab. Clin. Exp.
– volume: 347
  start-page: 1483
  year: 2002
  end-page: 1492
  ident: bib34
  article-title: Effects of the amount and intensity of exercise on plasma lipoproteins
  publication-title: N. Engl. J. Med.
– volume: 95
  start-page: 86
  year: 2016
  end-page: 92
  ident: bib63
  article-title: Changes in serum levels of perfluoroalkyl substances during a 10-year follow-up period in a large population-based cohort
  publication-title: Environ. Int.
– volume: 95
  start-page: 86
  year: 2016
  end-page: 92
  ident: bib62
  article-title: Changes in serum levels of perfluoroalkyl substances during a 10-year follow-up period in a large population-based cohort
  publication-title: Environ. Int.
– volume: 25
  start-page: 2368
  year: 2005
  end-page: 2375
  ident: bib39
  article-title: A comparison of three different methods to evaluate endothelium-dependent vasodilation in the elderly
  publication-title: Arterioscler. Thromb. Vasc. Biol.
– year: 2010
  ident: bib49
  publication-title: Gene Expression Profiling in Wild-type and PPARα-Null Mice Exposed to Perfluorooctane Sulfonate Reveals PPARα-independent Effects
– volume: 102
  start-page: 1
  year: 2020
  end-page: 36
  ident: bib47
  article-title: Per- and polyfluoroalkyl substances and obesity, type 2 diabetes and non-alcoholic fatty liver disease: a review of epidemiologic findings
  publication-title: Toxicol. Environ. Chem.
– volume: 51
  start-page: 2508
  year: 2017
  end-page: 2518
  ident: bib68
  article-title: A never-ending story of per- and polyfluoroalkyl substances (PFASs)?
  publication-title: Environ. Sci. Technol.
– volume: 158
  start-page: 106964
  year: 2022
  ident: bib11
  article-title: Per- and polyfluoroalkyl substance (PFAS) exposure, maternal metabolomic perturbation, and fetal growth in African American women: a meet-in-the-middle approach
  publication-title: Environ. Int.
– volume: 160
  start-page: 314
  year: 2018
  end-page: 321
  ident: bib32
  article-title: Perfluoroalkyl substances, bone density, and cardio-metabolic risk factors in obese 8-12 year old children: a pilot study
  publication-title: Environ. Res.
– volume: 34
  start-page: 351
  year: 2004
  end-page: 384
  ident: bib30
  article-title: The toxicology of perfluorooctanoate
  publication-title: Crit. Rev. Toxicol.
– volume: 164
  start-page: 860
  year: 2010
  end-page: 869
  ident: bib23
  article-title: Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project
  publication-title: Arch. Pediatr. Adolesc. Med.
– volume: 168
  start-page: 519
  year: 2019
  end-page: 534
  ident: bib46
  article-title: Dose effects of ammonium perfluorooctanoate on lipoprotein metabolism in APOE*3-Leiden.CETP mice
  publication-title: Toxicol. Sci. : an official journal of the Society of Toxicology
– volume: 33
  start-page: 546
  year: 2012
  end-page: 551
  ident: bib71
  article-title: Activation of mouse and human peroxisome proliferator-activated receptor-alpha (PPARα) by perfluoroalkyl acids (PFAAs): further investigation of C4-C12 compounds
  publication-title: Reprod. Toxicol.
– volume: 29
  start-page: 1678
  year: 2010
  end-page: 1688
  ident: bib16
  article-title: Determining the molecular interactions of perfluorinated carboxylic acids with human sera and isolated human serum albumin using nuclear magnetic resonance spectroscopy
  publication-title: Environ. Toxicol. Chem.
– volume: 62
  start-page: 104
  year: 2014
  end-page: 112
  ident: bib59
  article-title: Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study
  publication-title: Environ. Int.
– volume: 288
  start-page: 8
  issue: 1–3
  year: 2011
  ident: 10.1016/j.envres.2022.112903_bib7
  article-title: Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes
  publication-title: Toxicology
  doi: 10.1016/j.tox.2011.06.012
– volume: 71
  start-page: 1526
  issue: 23
  year: 2008
  ident: 10.1016/j.envres.2022.112903_bib15
  article-title: Altered fatty acid homeostasis and related toxicologic sequelae in rats exposed to dietary potassium perfluorooctanesulfonate (PFOS)
  publication-title: J. Toxicol. Environ. Health Part A
  doi: 10.1080/15287390802361763
– volume: 46
  start-page: 335
  issue: 3
  year: 2017
  ident: 10.1016/j.envres.2022.112903_bib4
  article-title: A review of contamination of surface-, ground-, and drinking water in Sweden by perfluoroalkyl and polyfluoroalkyl substances (PFASs)
  publication-title: Ambio
  doi: 10.1007/s13280-016-0848-8
– volume: 110
  start-page: 710
  issue: 7
  year: 2010
  ident: 10.1016/j.envres.2022.112903_bib12
  article-title: Effects of perfluorooctanesulfonate exposure on plasma lipid levels in the Inuit population of Nunavik (Northern Quebec)
  publication-title: Environ. Res.
  doi: 10.1016/j.envres.2010.07.003
– volume: 220
  start-page: 203
  issue: 2–3
  year: 2006
  ident: 10.1016/j.envres.2022.112903_bib41
  article-title: Comparative responses of rats and mice exposed to linear/branched, linear, or branched ammonium perfluorooctanoate (APFO)
  publication-title: Toxicology
  doi: 10.1016/j.tox.2006.01.003
– volume: 49
  start-page: 872
  issue: 8
  year: 2007
  ident: 10.1016/j.envres.2022.112903_bib52
  article-title: Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluorooctanoate
  publication-title: J. Occup. Environ. Med.
  doi: 10.1097/JOM.0b013e318124a93f
– volume: 91
  start-page: 2365
  issue: 6
  year: 2017
  ident: 10.1016/j.envres.2022.112903_bib1
  article-title: Activation of nuclear receptor CAR by an environmental pollutant perfluorooctanoic acid
  publication-title: Arch. Toxicol.
  doi: 10.1007/s00204-016-1888-3
– volume: 106
  start-page: 246
  year: 2014
  ident: 10.1016/j.envres.2022.112903_bib24
  article-title: Associations between serum concentrations of perfluoroalkyl acids and serum lipid levels in a Chinese population
  publication-title: Ecotoxicol. Environ. Saf.
  doi: 10.1016/j.ecoenv.2014.04.039
– volume: 29
  start-page: 1678
  issue: 8
  year: 2010
  ident: 10.1016/j.envres.2022.112903_bib16
  article-title: Determining the molecular interactions of perfluorinated carboxylic acids with human sera and isolated human serum albumin using nuclear magnetic resonance spectroscopy
  publication-title: Environ. Toxicol. Chem.
  doi: 10.1002/etc.204
– volume: 56
  start-page: 444
  issue: 4
  year: 2007
  ident: 10.1016/j.envres.2022.112903_bib28
  article-title: Endurance exercise training raises high-density lipoprotein cholesterol and lowers small low-density lipoprotein and very low-density lipoprotein independent of body fat phenotypes in older men and women
  publication-title: Metab. Clin. Exp.
  doi: 10.1016/j.metabol.2006.10.019
– volume: 117
  start-page: 196
  year: 2018
  ident: 10.1016/j.envres.2022.112903_bib56
  article-title: Changes in markers of liver function in relation to changes in perfluoroalkyl substances - a longitudinal study
  publication-title: Environ. Int.
  doi: 10.1016/j.envint.2018.04.052
– year: 2012
  ident: 10.1016/j.envres.2022.112903_bib22
– volume: 129
  start-page: 203
  year: 2015
  ident: 10.1016/j.envres.2022.112903_bib43
  article-title: PFAS concentrations in plasma samples from Danish school children and their mothers
  publication-title: Chemosphere
  doi: 10.1016/j.chemosphere.2014.07.018
– volume: 17
  start-page: 103
  issue: 12
  year: 2021
  ident: 10.1016/j.envres.2022.112903_bib58
  article-title: Prenatal exposure to poly-/per-fluoroalkyl substances is associated with alteration of lipid profiles in cord-blood
  publication-title: Metabolomics : Official journal of the Metabolomic Society
  doi: 10.1007/s11306-021-01853-9
– volume: 106
  start-page: 162
  issue: 1
  year: 2008
  ident: 10.1016/j.envres.2022.112903_bib70
  article-title: Activation of mouse and human peroxisome Proliferator−Activated receptor alpha by perfluoroalkyl acids of different functional groups and chain lengths
  publication-title: Toxicol. Sci.
  doi: 10.1093/toxsci/kfn166
– volume: 145
  start-page: 106091
  year: 2020
  ident: 10.1016/j.envres.2022.112903_bib13
  article-title: Dysregulated lipid and fatty acid metabolism link perfluoroalkyl substances exposure and impaired glucose metabolism in young adults
  publication-title: Environ. Int.
  doi: 10.1016/j.envint.2020.106091
– volume: 357
  start-page: 2109
  issue: 21
  year: 2007
  ident: 10.1016/j.envres.2022.112903_bib5
  article-title: Effects of torcetrapib in patients at high risk for coronary events
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa0706628
– volume: 19
  start-page: 33
  issue: 1
  year: 2020
  ident: 10.1016/j.envres.2022.112903_bib37
  article-title: Associations between perfluoroalkyl substances and serum lipids in a Swedish adult population with contaminated drinking water
  publication-title: Environ. Health : a global access science source.
  doi: 10.1186/s12940-020-00588-9
– volume: 102
  start-page: 1
  issue: 1–4
  year: 2020
  ident: 10.1016/j.envres.2022.112903_bib47
  article-title: Per- and polyfluoroalkyl substances and obesity, type 2 diabetes and non-alcoholic fatty liver disease: a review of epidemiologic findings
  publication-title: Toxicol. Environ. Chem.
  doi: 10.1080/02772248.2020.1763997
– volume: 45
  start-page: 10691
  issue: 24
  year: 2011
  ident: 10.1016/j.envres.2022.112903_bib38
  article-title: Associations between levels of serum perfluorinated chemicals and adiponectin in a young hypertension cohort in Taiwan
  publication-title: Environ. Sci. Technol.
  doi: 10.1021/es201964x
– volume: 512–513
  start-page: 397
  year: 2015
  ident: 10.1016/j.envres.2022.112903_bib14
  article-title: Concentration and correlations of perfluoroalkyl substances in whole blood among subjects from three different geographical areas in Korea
  publication-title: Sci. Total Environ.
  doi: 10.1016/j.scitotenv.2015.01.070
– volume: 33
  start-page: 546
  issue: 4
  year: 2012
  ident: 10.1016/j.envres.2022.112903_bib71
  article-title: Activation of mouse and human peroxisome proliferator-activated receptor-alpha (PPARα) by perfluoroalkyl acids (PFAAs): further investigation of C4-C12 compounds
  publication-title: Reprod. Toxicol.
  doi: 10.1016/j.reprotox.2011.09.009
– volume: 122
  start-page: 1299
  issue: 12
  year: 2014
  ident: 10.1016/j.envres.2022.112903_bib69
  article-title: Modeled PFOA exposure and coronary artery disease, hypertension, and high cholesterol in community and worker cohorts
  publication-title: Environ. Health Perspect.
  doi: 10.1289/ehp.1307943
– volume: 45
  start-page: 260
  issue: 3
  year: 2003
  ident: 10.1016/j.envres.2022.112903_bib45
  article-title: Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations
  publication-title: J. Occup. Environ. Med.
  doi: 10.1097/01.jom.0000052958.59271.10
– volume: 29
  start-page: 172
  issue: 2
  year: 2019
  ident: 10.1016/j.envres.2022.112903_bib27
  article-title: Per and polyfluoroalkyl substances (PFAS) blood levels after contamination of a community water supply and comparison with 2013–2014 NHANES
  publication-title: J. Expo. Sci. Environ. Epidemiol.
  doi: 10.1038/s41370-018-0096-z
– volume: 512–513
  start-page: 364
  year: 2015
  ident: 10.1016/j.envres.2022.112903_bib72
  article-title: Association of polyfluoroalkyl chemical exposure with serum lipids in children
  publication-title: Sci. Total Environ.
  doi: 10.1016/j.scitotenv.2015.01.042
– volume: 187
  start-page: 611
  issue: 10
  year: 2015
  ident: 10.1016/j.envres.2022.112903_bib9
  article-title: Assessment on the distribution and partitioning of perfluorinated compounds in the water and sediment of Nansi Lake, China
  publication-title: Environ. Monit. Assess.
  doi: 10.1007/s10661-015-4831-9
– volume: 25
  start-page: 2368
  issue: 11
  year: 2005
  ident: 10.1016/j.envres.2022.112903_bib39
  article-title: A comparison of three different methods to evaluate endothelium-dependent vasodilation in the elderly
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/01.ATV.0000184769.22061.da
– year: 2014
  ident: 10.1016/j.envres.2022.112903_bib26
– volume: 103
  start-page: 46
  issue: 1
  year: 2008
  ident: 10.1016/j.envres.2022.112903_bib48
  article-title: Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPAR alpha and CAR
  publication-title: Toxicol. Sci. : an official journal of the Society of Toxicology
  doi: 10.1093/toxsci/kfn025
– volume: 99
  start-page: 366
  issue: 2
  year: 2007
  ident: 10.1016/j.envres.2022.112903_bib35
  article-title: Perfluoroalkyl acids: a review of monitoring and toxicological findings
  publication-title: Toxicol. Sci.
  doi: 10.1093/toxsci/kfm128
– volume: 19
  start-page: 33
  issue: 1
  year: 2020
  ident: 10.1016/j.envres.2022.112903_bib36
  article-title: Associations between perfluoroalkyl substances and serum lipids in a Swedish adult population with contaminated drinking water
  publication-title: Environ. Health : a global access science source.
  doi: 10.1186/s12940-020-00588-9
– volume: 170
  start-page: 1268
  issue: 10
  year: 2009
  ident: 10.1016/j.envres.2022.112903_bib61
  article-title: Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant
  publication-title: Am. J. Epidemiol.
  doi: 10.1093/aje/kwp279
– volume: 17
  start-page: 59
  issue: 1
  year: 2018
  ident: 10.1016/j.envres.2022.112903_bib40
  article-title: Changes in plasma levels of perfluoroalkyl substances (PFASs) are related to increase in carotid intima-media thickness over 10 years - a longitudinal study
  publication-title: Environ. Health : a global access science source
  doi: 10.1186/s12940-018-0403-0
– volume: 95
  start-page: 86
  year: 2016
  ident: 10.1016/j.envres.2022.112903_bib63
  article-title: Changes in serum levels of perfluoroalkyl substances during a 10-year follow-up period in a large population-based cohort
  publication-title: Environ. Int.
  doi: 10.1016/j.envint.2016.08.002
– volume: 387
  start-page: 95
  year: 2017
  ident: 10.1016/j.envres.2022.112903_bib50
  article-title: PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling
  publication-title: Toxicology
  doi: 10.1016/j.tox.2017.05.013
– volume: 62
  start-page: 104
  year: 2014
  ident: 10.1016/j.envres.2022.112903_bib60
  article-title: Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study
  publication-title: Environ. Int.
  doi: 10.1016/j.envint.2013.10.004
– volume: 85
  start-page: 619
  issue: 2
  year: 2014
  ident: 10.1016/j.envres.2022.112903_bib74
  article-title: Perfluoroalkyl and polyfluoroalkyl substances in sediments from South Bohai coastal watersheds, China
  publication-title: Mar. Pollut. Bull.
  doi: 10.1016/j.marpolbul.2013.12.042
– volume: 34
  start-page: 396
  issue: 4
  year: 2011
  ident: 10.1016/j.envres.2022.112903_bib31
  article-title: Tenuous dose-response correlations for common disease states: case study of cholesterol and perfluorooctanoate/sulfonate (PFOA/PFOS) in the C8 Health Project
  publication-title: Drug Chem. Toxicol.
  doi: 10.3109/01480545.2011.582502
– volume: 1305
  start-page: 164
  year: 2013
  ident: 10.1016/j.envres.2022.112903_bib55
  article-title: A rapid method for the determination of perfluoroalkyl substances including structural isomers of perfluorooctane sulfonic acid in human serum using 96-well plates and column-switching ultra-high performance liquid chromatography tandem mass spectrometry
  publication-title: J. Chromatogr. A
  doi: 10.1016/j.chroma.2013.07.026
– volume: 168
  start-page: 519
  issue: 2
  year: 2019
  ident: 10.1016/j.envres.2022.112903_bib46
  article-title: Dose effects of ammonium perfluorooctanoate on lipoprotein metabolism in APOE*3-Leiden.CETP mice
  publication-title: Toxicol. Sci. : an official journal of the Society of Toxicology
  doi: 10.1093/toxsci/kfz015
– volume: 29
  start-page: 131
  issue: 2
  year: 2019
  ident: 10.1016/j.envres.2022.112903_bib65
  article-title: A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects
  publication-title: J. Expo. Sci. Environ. Epidemiol.
  doi: 10.1038/s41370-018-0094-1
– volume: 1820
  start-page: 1092
  issue: 7
  year: 2012
  ident: 10.1016/j.envres.2022.112903_bib67
  article-title: PFOS-induced hepatic steatosis, the mechanistic actions on β-oxidation and lipid transport
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbagen.2012.03.010
– volume: 158
  start-page: 106964
  year: 2022
  ident: 10.1016/j.envres.2022.112903_bib11
  article-title: Per- and polyfluoroalkyl substance (PFAS) exposure, maternal metabolomic perturbation, and fetal growth in African American women: a meet-in-the-middle approach
  publication-title: Environ. Int.
  doi: 10.1016/j.envint.2021.106964
– year: 2010
  ident: 10.1016/j.envres.2022.112903_bib49
– volume: 164
  start-page: 860
  issue: 9
  year: 2010
  ident: 10.1016/j.envres.2022.112903_bib23
  article-title: Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project
  publication-title: Arch. Pediatr. Adolesc. Med.
  doi: 10.1001/archpediatrics.2010.163
– volume: 159
  start-page: 95
  year: 2017
  ident: 10.1016/j.envres.2022.112903_bib64
  article-title: The effect of drinking water contaminated with perfluoroalkyl substances on a 10-year longitudinal trend of plasma levels in an elderly Uppsala cohort
  publication-title: Environ. Res.
  doi: 10.1016/j.envres.2017.07.050
– volume: 49
  start-page: 1086
  issue: 10
  year: 2007
  ident: 10.1016/j.envres.2022.112903_bib53
  article-title: Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers
  publication-title: J. Occup. Environ. Med.
  doi: 10.1097/JOM.0b013e318156eca3
– volume: 62
  start-page: 104
  year: 2014
  ident: 10.1016/j.envres.2022.112903_bib59
  article-title: Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study
  publication-title: Environ. Int.
  doi: 10.1016/j.envint.2013.10.004
– year: 2014
  ident: 10.1016/j.envres.2022.112903_bib2
– volume: 118
  start-page: 197
  issue: 2
  year: 2010
  ident: 10.1016/j.envres.2022.112903_bib44
  article-title: Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population
  publication-title: Environ. Health Perspect.
  doi: 10.1289/ehp.0901165
– volume: 111
  start-page: 1
  year: 2018
  ident: 10.1016/j.envres.2022.112903_bib42
  article-title: Early life exposure to per- and polyfluoroalkyl substances and mid-childhood lipid and alanine aminotransferase levels
  publication-title: Environ. Int.
  doi: 10.1016/j.envint.2017.11.008
– volume: 347
  start-page: 1483
  issue: 19
  year: 2002
  ident: 10.1016/j.envres.2022.112903_bib34
  article-title: Effects of the amount and intensity of exercise on plasma lipoproteins
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa020194
– volume: 56
  start-page: 259
  issue: 3
  year: 2010
  ident: 10.1016/j.envres.2022.112903_bib10
  article-title: Reference values for 27 clinical chemistry tests in 70-year-old males and females
  publication-title: Gerontology
  doi: 10.1159/000251722
– volume: 380
  start-page: 23
  year: 2017
  ident: 10.1016/j.envres.2022.112903_bib73
  article-title: Poly- and perfluorinated compounds activate human pregnane X receptor
  publication-title: Toxicology
  doi: 10.1016/j.tox.2017.01.012
– volume: 24
  start-page: 569
  issue: 4
  year: 2013
  ident: 10.1016/j.envres.2022.112903_bib21
  article-title: Reductions in serum lipids with a 4-year decline in serum perfluorooctanoic acid and perfluorooctanesulfonic acid
  publication-title: Epidemiology
  doi: 10.1097/EDE.0b013e31829443ee
– volume: 95
  start-page: 86
  year: 2016
  ident: 10.1016/j.envres.2022.112903_bib62
  article-title: Changes in serum levels of perfluoroalkyl substances during a 10-year follow-up period in a large population-based cohort
  publication-title: Environ. Int.
  doi: 10.1016/j.envint.2016.08.002
– volume: 51
  start-page: 2508
  issue: 5
  year: 2017
  ident: 10.1016/j.envres.2022.112903_bib68
  article-title: A never-ending story of per- and polyfluoroalkyl substances (PFASs)?
  publication-title: Environ. Sci. Technol.
  doi: 10.1021/acs.est.6b04806
– volume: 8
  issue: 2
  year: 2013
  ident: 10.1016/j.envres.2022.112903_bib19
  article-title: Association between plasma PFOA and PFOS levels and total cholesterol in a middle-aged Danish population
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0056969
– volume: 129
  start-page: 249
  issue: 2
  year: 1989
  ident: 10.1016/j.envres.2022.112903_bib3
  article-title: Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond
  publication-title: Am. J. Epidemiol.
  doi: 10.1093/oxfordjournals.aje.a115130
– volume: 82
  start-page: 28
  year: 2015
  ident: 10.1016/j.envres.2022.112903_bib51
  article-title: Elevated levels of PFOS and PFHxS in firefighters exposed to aqueous film forming foam (AFFF)
  publication-title: Environ. Int.
  doi: 10.1016/j.envint.2015.05.005
– volume: 36
  start-page: 539
  issue: 9
  year: 2015
  ident: 10.1016/j.envres.2022.112903_bib29
  article-title: Mendelian randomization of blood lipids for coronary heart disease
  publication-title: Eur. Heart J.
  doi: 10.1093/eurheartj/eht571
– volume: 34
  start-page: 351
  issue: 4
  year: 2004
  ident: 10.1016/j.envres.2022.112903_bib30
  article-title: The toxicology of perfluorooctanoate
  publication-title: Crit. Rev. Toxicol.
  doi: 10.1080/10408440490464705
– volume: 98
  start-page: 78
  year: 2014
  ident: 10.1016/j.envres.2022.112903_bib25
  article-title: The association between PFOA, PFOS and serum lipid levels in adolescents
  publication-title: Chemosphere
  doi: 10.1016/j.chemosphere.2013.10.005
– volume: 160
  start-page: 314
  year: 2018
  ident: 10.1016/j.envres.2022.112903_bib32
  article-title: Perfluoroalkyl substances, bone density, and cardio-metabolic risk factors in obese 8-12 year old children: a pilot study
  publication-title: Environ. Res.
  doi: 10.1016/j.envres.2017.10.014
– volume: 405
  start-page: 115204
  year: 2020
  ident: 10.1016/j.envres.2022.112903_bib57
  article-title: Perfluorooctanoic acid activates multiple nuclear receptor pathways and skews expression of genes regulating cholesterol homeostasis in liver of humanized PPARα mice fed an American diet
  publication-title: Toxicol. Appl. Pharmacol.
  doi: 10.1016/j.taap.2020.115204
– volume: 378
  start-page: 37
  year: 2017
  ident: 10.1016/j.envres.2022.112903_bib17
  article-title: Perfluoroalkyl acids-induced liver steatosis: effects on genes controlling lipid homeostasis
  publication-title: Toxicology
  doi: 10.1016/j.tox.2016.12.007
– volume: 293
  start-page: 16
  issue: 1–3
  year: 2012
  ident: 10.1016/j.envres.2022.112903_bib18
  article-title: Hepatocellular hypertrophy and cell proliferation in Sprague-Dawley rats from dietary exposure to potassium perfluorooctanesulfonate results from increased expression of xenosensor nuclear receptors PPARα and CAR/PXR
  publication-title: Toxicology
  doi: 10.1016/j.tox.2011.12.014
– volume: 8
  issue: 2
  year: 2013
  ident: 10.1016/j.envres.2022.112903_bib20
  article-title: Association between plasma PFOA and PFOS levels and total cholesterol in a middle-aged Danish population
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0056969
– volume: 62
  start-page: 104700
  year: 2020
  ident: 10.1016/j.envres.2022.112903_bib6
  article-title: Activation of human nuclear receptors by perfluoroalkylated substances (PFAS)
  publication-title: Toxicol. Vitro
  doi: 10.1016/j.tiv.2019.104700
– volume: 92
  start-page: 476
  issue: 2
  year: 2006
  ident: 10.1016/j.envres.2022.112903_bib66
  article-title: Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-α, -β, and -γ, liver X receptor-β, and retinoid X receptor-α
  publication-title: Toxicol. Sci.
  doi: 10.1093/toxsci/kfl014
– volume: 109
  start-page: 128
  year: 2017
  ident: 10.1016/j.envres.2022.112903_bib33
  article-title: Serum perfluoroalkyl substances and cardiometabolic consequences in adolescents exposed to the World Trade Center disaster and a matched comparison group
  publication-title: Environ. Int.
  doi: 10.1016/j.envint.2017.08.003
– volume: 49
  start-page: 872
  issue: 8
  year: 2007
  ident: 10.1016/j.envres.2022.112903_bib54
  article-title: Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluorooctanoate
  publication-title: J. Occup. Environ. Med.
  doi: 10.1097/JOM.0b013e318124a93f
– volume: 145
  start-page: 106117
  year: 2020
  ident: 10.1016/j.envres.2022.112903_bib8
  article-title: Associations between perfluoroalkyl substances and lipid profile in a highly exposed young adult population in the Veneto Region
  publication-title: Environ. Int.
  doi: 10.1016/j.envint.2020.106117
SSID ssj0011530
Score 2.576364
Snippet Associations between per- and polyfluoroalkyl substances (PFAS), mainly PFOS and PFOA, and increased blood lipids have been reported primarily from...
BACKGROUND: Associations between per- and polyfluoroalkyl substances (PFAS), mainly PFOS and PFOA, and increased blood lipids have been reported primarily from...
Background: Associations between per-and polyfluoroalkyl substances (PFAS), mainly PFOS and PFOA, and increased blood lipids have been reported primarily from...
SourceID swepub
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 112903
SubjectTerms and polyfluoroalkyl substances
confidence interval
drug therapy
Dyslipidemia
Epidemiology
high density lipoprotein cholesterol
humans
lipid metabolism
longitudinal studies
Longitudinal study
low density lipoprotein cholesterol
Per
Per- and polyfluoroalkyl substances
PFAS
physical activity
Plasma lipids
prospective studies
regression analysis
Sweden
tandem mass spectrometry
Title Changes in plasma levels of per- and polyfluoroalkyl substances (PFAS) are associated with changes in plasma lipids - A longitudinal study over 10 years
URI https://dx.doi.org/10.1016/j.envres.2022.112903
https://www.ncbi.nlm.nih.gov/pubmed/35231461
https://www.proquest.com/docview/2635243630
https://www.proquest.com/docview/2675563864
https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-97722
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-473964
Volume 211
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9QwEA_H-SKI6Onp-nGMoKAP9dokbbePy3nLqngInnJvIW2ao1rb0m6FffHv8M91pmlXdOEOfCj0Y1LazmTySzq_GcaeGyN8Lbj10jS1npyn3EuEzT2RWonjQ-ynIRGFP5xFq8_y3UV4scdOJi4MhVWOvt_59MFbj2eOx6953BQFcXwD4pUGnA9AmnKCShmTlb_-uQ3zQMAj_KmKAUlP9LkhxiuvfuCkFmeJnBOXJplKZ-0OT7vw85_cosN4tLzDbo9AEhbuWe-yvbw6YIenf3hreHHsuN0Bu-WW58Cxju6xX45V0EFRQYMA-ruGksKHOqgtNHnrga4MNHW5sWVft7Uuv21K6NDLrMlMOnj5cbn49Ap0m4MeNZwboFVdyHZvXTSF6cCDBZQ1FUjqDRXjgiG3LVAQKQQ-bLDTdffZ-fL0_GTljUUavAyh0NqLMh4bRFkGgZINg1gjprGIOnQUmCyQRspMmLkJY9zLBc63k9QkOhEaW8XSF4dsv6qr_CEDEdpcxDFCGEpaJ3TK9dxqbUJh0dNwPmNiUo3KxgTmVEejVFOk2lflFKpIocopdMa8bavGJfC4Rj6etK7-MkSFY8w1LZ9NRqKwj9KPF13ldY9CiOq4FJHwr5KJKVfbPJIz9sBZ2PZ5sbWg-usz9sKZ3PYKJQd_U3xZqLq9xK1XCOfpS10p1_dKxiKJ5KP_ftfH7CYduUjIJ2x_3fb5U0Rn6_Ro6H5H7Mbi7fvV2W-gJTrH
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdG9wASQjDYKJ-HBBI8REtsJ2keq7GqY1uFREF7s5zYRoGQREmD1P-EP5dznRRBpU3ioVJU-6Ik9-Gfk_vdEfJaKeZLRo2Xpqnx-CSlXsKM9lhqOK4PsZ-Glih8uYjmn_mHq_Bqj5wMXBibVtnHfhfTN9G6_-e4f5rHdZ5bjm9geaUBpRsgzW-RfVudKhyR_enZ-Xyx_ZiATu0PjQyswMCg26R56fIn7mtxo0ippdMkQ_es3RVqF4H-U150syTN7pN7PZaEqbvcB2RPlwfk8PQPdQ0He99tD8hd94YOHPHoIfnliAUt5CXUiKF_SChsBlELlYFaNx7IUkFdFWtTdFVTyeL7uoAWA83KWkoLbz_Opp_egWw0yF7JWoF9sQvZ7qnzOlcteDCForI9kjpl-3HBprwt2DxSCHxYo9-1j8hydro8mXt9nwYvQzS08qKMxgqBlkKsZMIglghrDAIPGQUqC7jiPGNqosIYjzTDLXeSqkQmTKJUzH12SEZlVerHBFhoNItjRDG2bh2TKZUTI6UKmcFgQ-mYsEE1IutrmNtWGoUYktW-CadQYRUqnELHxNtK1a6Gxw3z40Hr4i9bFLjM3CD5ajASgW5qv73IUlcdTkJgRzmLmH_dnNiWa5tEfEyOnIVtrxelmW3BPiZvnMltR2x98Pf5l6momq_46wQievukrp3XdYLHLIn4k_--15fk9nx5eSEuzhbnT8kdO-ISI5-R0arp9HMEa6v0Re-MvwFHRD14
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Changes+in+plasma+levels+of+per-+and+polyfluoroalkyl+substances+%28PFAS%29+are+associated+with+changes+in+plasma+lipids+-+A+longitudinal+study+over+10+years&rft.jtitle=Environmental+research&rft.au=Dunder%2C+Linda&rft.au=Lind%2C+P.+Monica&rft.au=Salihovic%2C+Samira&rft.au=Stubleski%2C+Jordan&rft.date=2022-08-01&rft.pub=Elsevier+Inc&rft.issn=0013-9351&rft.eissn=1096-0953&rft.volume=211&rft_id=info:doi/10.1016%2Fj.envres.2022.112903&rft.externalDocID=S0013935122002304
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0013-9351&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0013-9351&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0013-9351&client=summon